Pharmaceutical manufacturer for Peg 3350

Founded in 1978, Biocon Limited is the largest biotechnology company in India and a leading company in Asia, focusing on biopharmaceuticals and research services. It is an integrated and innovation-driven enterprise that provides affordable solutions for chronic diseases globally. The company develops, manufactures, and offers a diverse portfolio of Small Molecules APIs & Formulations and Complex Biologics, including Novels and Biosimilars like MAbs, rh-insulin& Insulin Analogs. Among its notable products are the world's first Pichia-based recombinant human Insulin, INSUGEN, Glargine, BASALOG, and India's first biologic BioMAb-EGFR for head and neck cancer. Additionally, it has developed Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, introduced as Alzumab for psoriasis in India in 2013.

Bachem offers a comprehensive array of services to the pharmaceutical and biotechnology sectors. It specializes in creating innovative and efficient manufacturing procedures, as well as the dependable production of peptide-based active pharmaceutical ingredients. The company is headquartered in Switzerland and has branch offices in Europe, the United States, and Asia, thus ensuring a worldwide presence with greater expertise.

Discover excipients provided by Avesta Pharma for utilization in pharmaceutical delivery systems (DDS). Additionally, explore the contact information and details concerning Avesta Pharma's regulatory submissions (DMFs), cGMP inspections, accreditations, etc.

TIL Healthcare is a global pharmaceutical corporation that provides a diverse range of products in Liquids, Capsules, Tablets, Injectables, Soft-gel & Powders. Operating in over 54 countries spanning Asia, Africa, Latin America, Europe, and CIS. Til holds 750+ Product Registrations and operates 5+ Manufacturing Facilities. The tablet plant has a capacity of 4 Billion, capsules with 300 Million, syrup with 25 Million, sachets/dry powder with 10 Million, and SVP/LVP with 10 Million, with EUGMP, GMP, and ISO approvals. I M Healthcare has an exclusive unit in Himachal Pradesh, India dedicated to manufacturing Gummies, utilizing technology from Europe and the USA. Gummy Vitamins are a new form of dosage with top-quality infrastructure and efficient workflow, capable of providing Contract Manufacturing Services or Private Label/3rd Party Services. Consequently, we not only serve as your healthcare partners but also as your business partners, offering Expert Resources, exceptional development, and Packaging processes.

Clariant, a leading company in specialized chemicals, has reached a significant milestone in its China strategy by appointing Fu Cai Wang as the new China President, effective from December 1, 2018. In this capacity, he serves as the Business Unit Head for Clariant's operations in China. Fu Cai Wang transitions to Clariant from Arkema, where he held the roles of Asia Pacific Regional Group President for the Fluorochemicals Business Unit and President of Arkema Hebei Casda Biomaterials Co. Ltd. The addition of Fu Cai Wang fulfills the 'Local Empowerment' component of Clariant's dedicated 5 Locals (5Ls) strategic framework, which was established to advance the company.

The company specializes in manufacturing pharmaceutical polyethylene glycol (PEG) products and has established collaborative ties with Petrochina for numerous years. It was publicly listed in China in 2008 and has an annual output of 20000, serving as a strategic partner for several major domestic pharmaceutical companies. Its products are exported to Europe, South America, Australia, East Asia, and other regions. The company is in the process of obtaining CEP certification.